- Home
- ASRV vs MAIA Comparison
ASRV vs MAIA Comparison
Compare ASRV & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- MAIA
- Stock Information
- Founded
- ASRV 1983
- MAIA 2018
- Country
- ASRV United States
- MAIA United States
- Employees
- ASRV N/A
- MAIA N/A
- Industry
- ASRV Major Banks
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- ASRV Finance
- MAIA Health Care
- Exchange
- ASRV Nasdaq
- MAIA Nasdaq
- Market Cap
- ASRV 40.1M
- MAIA 46.7M
- IPO Year
- ASRV N/A
- MAIA 2022
- Fundamental
- Price
- ASRV $2.81
- MAIA $1.77
- Analyst Decision
- ASRV
- MAIA
- Analyst Count
- ASRV 0
- MAIA 0
- Target Price
- ASRV N/A
- MAIA N/A
- AVG Volume (30 Days)
- ASRV 21.7K
- MAIA 274.6K
- Earning Date
- ASRV 07-15-2025
- MAIA 05-09-2025
- Dividend Yield
- ASRV 4.30%
- MAIA N/A
- EPS Growth
- ASRV N/A
- MAIA N/A
- EPS
- ASRV 0.22
- MAIA N/A
- Revenue
- ASRV $53,037,000.00
- MAIA N/A
- Revenue This Year
- ASRV N/A
- MAIA N/A
- Revenue Next Year
- ASRV N/A
- MAIA N/A
- P/E Ratio
- ASRV $12.97
- MAIA N/A
- Revenue Growth
- ASRV 16.87
- MAIA N/A
- 52 Week Low
- ASRV $2.03
- MAIA $1.40
- 52 Week High
- ASRV $3.06
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- ASRV 79.00
- MAIA 47.79
- Support Level
- ASRV $2.64
- MAIA $1.71
- Resistance Level
- ASRV $2.67
- MAIA $1.85
- Average True Range (ATR)
- ASRV 0.10
- MAIA 0.13
- MACD
- ASRV 0.03
- MAIA -0.02
- Stochastic Oscillator
- ASRV 97.46
- MAIA 25.64
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.